The first pick would be in the pharma space, we are seeing quite good momentum here today, so pharma you can see Syngene which is giving you a good fresh breakout above 700 level so I think it is looking quite positive from current levels to test higher targets of 720, 725.
Nifty faces further downside after breaking key support levels: Rohit Srivastava
Rohit Srivastava, Founder of Strike Money Analytics, highlights the impacts of a rising dollar and bond yields on the Nifty, predicting further downside with significant